Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?

SS Karuppagounder, RR Ratan - Journal of Cerebral Blood …, 2012 - journals.sagepub.com
A major challenge in developing stroke therapeutics that augment adaptive pathways to
stress has been to identify targets that can activate compensatory programs without inducing …

Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection

SK Harten, M Ashcroft, PH Maxwell - Antioxidants & redox signaling, 2010 - liebertpub.com
Ischemic stroke is a major cause of death worldwide, and current therapeutic options are
very limited. Preconditioning with an ischemic or hypoxic insult is beneficial in experimental …

[HTML][HTML] Hypoxia mimetic agents for ischemic stroke

CK Davis, SA Jain, ON Bae, A Majid… - Frontiers in cell and …, 2019 - frontiersin.org
Every year stroke claims more than 6 million lives worldwide. The majority of them are
ischemic stroke. Small molecule-based therapeutics for ischemic stroke has attracted a lot of …

[HTML][HTML] Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke

S Reischl, L Li, G Walkinshaw, LA Flippin, HH Marti… - PloS one, 2014 - journals.plos.org
Ischemic stroke results in disruption of the blood-brain barrier (BBB), edema formation and
neuronal cell loss. Some neuroprotective factors such as vascular endothelial growth factor …

Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice

RL Chen, S Nagel, M Papadakis… - The Journal of …, 2012 - Wiley Online Library
Key points• Cerebral ischaemia results in the activation of multiple pathways that can
independently lead to neuronal death. Agents targeting a number of processes at one time …

[HTML][HTML] Neuroprotective strategies for acute ischemic stroke: targeting oxidative stress and prolyl hydroxylase domain inhibition in synaptic signalling

M Puzio, N Moreton, JJ O'Connor - Brain Disorders, 2022 - Elsevier
Acute ischemic stroke (AIS) is the primary reason for sustained disability and the second
leading cause of death worldwide. Multiple complex mechanisms contribute to the …

[HTML][HTML] Reactive oxygen species formation in the brain at different oxygen levels: the role of hypoxia inducible factors

R Chen, UH Lai, L Zhu, A Singh, M Ahmed… - Frontiers in cell and …, 2018 - frontiersin.org
Hypoxia inducible factor (HIF) is the master oxygen sensor within cells and is central to the
regulation of cell responses to varying oxygen levels. HIF activation during hypoxia ensures …

Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia

R Kunze, W Zhou, R Veltkamp, B Wielockx, G Breier… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—Numerous factors involved in the adaptive response to hypoxia,
including erythropoietin and vascular endothelial growth factor are transcriptionally …

Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF-and CREB-independent …

A Siddiq, LR Aminova, CM Troy, K Suh… - Journal of …, 2009 - Soc Neuroscience
Oxidative stress contributes to tissue injury in conditions ranging from cardiovascular
disease to stroke, spinal cord injury, neurodegeneration, and perhaps even aging. Yet the …

Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α

ME Ogle, X Gu, AR Espinera, L Wei - Neurobiology of disease, 2012 - Elsevier
Pathological oxygen deprivation inhibits prolyl hydroxylase (PHD) activity and stimulates a
protective cellular oxygen-sensing response in part through the stabilization and activation …